Atlas Trials

Effectiveness of Tofacitinib in Systemic Sclerosis

Clinical trial NCT06044844 · UNKNOWN

Trial details

NCT number
NCT06044844
Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Efficacy of Tofacitinib in the Systemic Sclerosis
Start date
2023-11-01
Primary completion
2024-05-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.